FISCHER MEDICAL VENTURE L (FISCHER) financials

FISCHER MEDICAL VENTURE L (FISCHER) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Fischer Medical Ventures Ltd, earlier known asFischer Chemic Ltd, leads a healthcare-technology group. It makes and services medical-imaging equipment and providesAI-based health screening and digital-health solutions. Its MRI manufacturing plant is located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam.[1]

Market Cap: ₹2,032Cr.
Current Price: ₹29.1
ROE: -3.09%
ROCE: -1.58%
Book Value: ₹5.17
Dividend Yield: 0.17%
52W High / Low: ₹122/29.0

In Jun 2026, FISCHER MEDICAL VENTURE L (FISCHER) reported sales ₹0.72 Cr and net profit ₹-3.50 Cr.

Annual TTM: sales ₹14 Cr, net profit ₹-13 Cr.

Shareholding: Promoters 63.09% (Aug 2026), FIIs 5.57% (Aug 2026), DIIs 1.26% (Aug 2026), Public 30.09% (Aug 2026), No. of Shareholders 23,951% (Aug 2026).

FISCHER quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.00	5.22	4.54	7.43	1.32	4.11	0.72
Expenses	0.36	0.22	6.78	4.16	6.28	2.64	13.00	2.60
Operating Profit	-0.36	-0.22	-1.56	0.38	1.15	-1.32	-8.89	-1.88
OPM %	—	—	-29.89%	8.37%	15.48%	-100.00%	-216.30%	-261.11%
Other Income	0.82	0.87	0.65	0.80	1.43	0.86	0.43	0.89
Interest	0.00	0.00	0.12	1.31	1.12	0.96	1.27	1.47
Depreciation	0.00	0.03	0.10	0.08	0.08	0.08	0.43	0.77
Profit before tax	0.46	0.62	-1.13	-0.21	1.38	-1.50	-10.16	-3.23
Tax %	-10.87%	67.74%	-21.24%	185.71%	39.13%	11.33%	-11.71%	8.36%
Net Profit	0.51	0.20	-0.89	-0.61	0.84	-1.67	-8.98	-3.50
EPS in Rs	0.01	0.00	-0.01	-0.01	0.01	-0.03	-0.14	-0.05
Raw PDF	—	—	—	—	—	—	—	—

FISCHER profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0	0	0	0	12	5	17	14
Expenses	0	0	0	0	12	7	26	25
Operating Profit	-0	-0	-0	0	-0	-2	-9	-11
OPM %	-11%	-12%	—	11%	-1.6%	-43%	-50%	-81%
Other Income	0	0	0	0	1	3	3	4
Interest	0	0	0	0	0	0	5	5
Depreciation	0	0	0	0	0	0	1	1
Profit before tax	-0	-0	-0	0	1	1	-11	-14
Tax %	0%	-450%	20%	—	26%	30%	-1%	—
Net Profit	-0	0	-0	-0	0	1	-10	-13
EPS in Rs	-0.24	0.82	-1.35	-0.24	0.01	0.01	-0.16	-0.21
Dividend Payout %	0%	0%	0%	0%	0%	48%	-3%	—

FISCHER balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.17	0.17	0.17	0.17	0.17	54	64	65
Reserves	-0	-0	-0	-0	-0	26	272	273
Borrowings	0	0	0	0	1	0	22	46
Other Liabilities	0	0	0	0	0	12	1	5
Total Liabilities	0	0	0	0	0	92	358	389
Fixed Assets	0	0	0	0	0	0	1	11
CWIP	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	41	291	304
Other Assets	0	0	0	0	0	51	67	74
Total Assets	0	0	0	0	0	92	358	389

FISCHER cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	0	0	-0	-0	-0	0	-23	-3
Cash from Investing Activity	0	0	0	0	0	-38	-232	-13
Cash from Financing Activity	-0	0	0	0	0	38	255	17
Net Cash Flow	-0	0	-0	-0	0	-0	0	1
Free Cash Flow	0	0	-0	-0	-0	0	-23	-3
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	0%	-100%	300%	95%	-750%	-68%	1,004%	29%

FISCHER shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Aug 2026
Promoters	74.91%	62.82%	61.80%	61.80%	61.80%	62.15%	62.15%	63.09%
FIIs	5.07%	5.23%	5.55%	5.57%	4.85%	4.97%	5.48%	5.57%
DIIs	1.68%	1.44%	1.42%	1.42%	1.36%	1.38%	1.35%	1.26%
Public	18.32%	30.51%	31.23%	31.22%	31.99%	31.51%	31.01%	30.09%
No. of Shareholders	9,688	10,180	10,058	13,054	22,920	23,269	23,950	23,951

FISCHER key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0	0	0	—	345	402	1,194	435
Inventory Days	0	—	—	—	—	0	6	13
Days Payable	—	—	—	—	—	—	31	114
Cash Conversion Cycle	0	0	0	—	345	402	1,169	333
Working Capital Days	365	-41	21	—	-831	1,215	1,408	348
ROCE %	8%	-22%	-13%	-97%	9%	1%	0%	-2%

FISCHERUpdated 19 Oct 2026, 9:53

Fischer Medical Venture L

FISCHERUpdated 19 Oct 2026, 9:53

Market Cap

₹2,032Cr.

Current Price

₹29.1

High / Low

₹122/29.0

ROE-3.09%

ROCE-1.58%

Book Value₹5.17

Face Value₹1.00

Dividend Yield0.17%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	0	0.01	0.1	0	0	-0.11	100	-0.22	-0.09
Sep 2023	0.19	0	0.04	0.01	0	0.16	6.25	0.14	0.06
Dec 2023	0	0	0.14	0.01	0	-0.13	0	-0.13	-0.05
Mar 2024	11.34	0	11.43	0.72	0	0.63	4.76	0.6	0.01
Jun 2024	0	0	0.11	1.12	0	1.01	16.83	0.84	0.02
Sep 2024	0	0	0.36	0.82	0	0.46	-10.87	0.51	0.01
Dec 2024	0	0	0.22	0.87	0.03	0.62	67.74	0.2	0
Mar 2025	5.22	0.12	6.78	0.65	0.1	-1.13	-21.24	-0.89	-0.01
Jun 2025	4.54	1.31	4.16	0.8	0.08	-0.21	185.71	-0.61	-0.01
Sep 2025	7.43	1.12	6.28	1.43	0.08	1.38	39.13	0.84	0.01
Dec 2025	1.32	0.96	2.64	0.86	0.08	-1.5	11.33	-1.67	-0.03
Mar 2026	4.11	1.27	13	0.43	0.43	-10.16	-11.71	-8.98	-0.14
Jun 2026	0.72	1.47	2.6	0.89	0.77	-3.23	8.36	-3.5	-0.05

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	0	0	0	0	0	0	0	0	0.01
Mar 2016	0	0	0	0	0	0	0	0	-0.01
Mar 2017	0	0	0	0	0	0	0	0	-0.02
Mar 2018	0	0	0	0	0	0	—	0	0
Mar 2019	0	0	0	0	0	0	0	0	0
Mar 2020	0	0	0	0	0	0	0	0	-0.24
Mar 2021	0	0	0	0	0	0	-450	0	0.82
Mar 2022	0	0	0	0	0	0	20	0	-1.35
Mar 2023	0	0	0	0	0	0	—	0	-0.24
Mar 2024	12	0	12	1	0	1	26	0	0.01
Mar 2025	5	0	7	3	0	1	30	1	0.01
Mar 2026	17	5	26	3	1	-11	-1	-10	-0.16
TTM	14	5	25	4	1	-14	—	-13	-0.21

Shareholding pattern

As of Aug 2026%

Holder	Share
Promoters	63.09%
FIIs	5.57%
DIIs	1.26%
Public	30.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	0%	0%	0%	99.99%
Mar 2024	0%	5.07%	1.68%	93.24%
Jun 2024	74.91%	5.07%	1.68%	18.33%
Sep 2024	74.91%	5.07%	1.68%	18.33%
Dec 2024	74.91%	5.07%	1.68%	18.32%
Mar 2025	62.82%	5.23%	1.44%	30.51%
Jun 2025	61.8%	5.55%	1.42%	31.23%
Sep 2025	61.8%	5.57%	1.42%	31.22%
Dec 2025	61.8%	4.85%	1.36%	31.99%
Mar 2026	62.15%	4.97%	1.38%	31.51%
Jun 2026	62.15%	5.48%	1.35%	31.01%
Aug 2026	63.09%	5.57%	1.26%	30.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	Investments	Other Assets	Total Assets
Mar 2015	3	-3	0	0	0	0	0	0	0
Mar 2016	3	-3	0	0	0	0	0	0	0
Mar 2017	3	-4	0	0	0	0	0	0	0
Mar 2018	0.17	0	0	0	0	0	0	0	0
Mar 2019	0.17	0	0	0	0	0	0	0	0
Mar 2020	0.17	0	0	0	0	0	0	0	0
Mar 2021	0.17	0	0	0	0	0	0	0	0
Mar 2022	0.17	0	0	0	0	0	0	0	0
Mar 2023	0.17	0	1	0	0	0	0	0	0
Mar 2024	54	26	0	12	92	0	41	51	92
Mar 2025	64	272	22	1	358	1	291	67	358
Mar 2026	65	273	46	5	389	11	304	74	389

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0	0	0	0
Mar 2016	0	0	0	0
Mar 2017	0	0	0	0
Mar 2018	0	0	0	0
Mar 2019	0	0	0	0
Mar 2020	0	0	0	0
Mar 2021	0	0	0	0
Mar 2022	0	0	0	0
Mar 2023	0	0	0	0
Mar 2024	0	-38	38	0
Mar 2025	-23	-232	255	0
Mar 2026	-3	-13	17	1

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0	—	—	0	0	0	0	—	345	402	1,194	435
Inventory Days	—	—	—	0	0	—	—	—	—	0	6	13
Days Payable	—	—	—	—	—	—	—	—	—	—	31	114
Cash Conversion Cycle	0	—	—	0	0	0	0	—	345	402	1,169	333
Working Capital Days	-365	—	—	365	365	-41	21	—	-831	1,215	1,408	348
ROCE %	—	—	-350%	0%	8%	-22%	-13%	-97%	9%	1%	0%	-2%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of FISCHER MEDICAL VENTURE L (FISCHER)?

The reported market capitalisation for FISCHER MEDICAL VENTURE L (FISCHER) is ₹2,032Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of FISCHER?

The current price shown for FISCHER MEDICAL VENTURE L (FISCHER) on Fincrux is ₹29.1 with a 52-week high/low of ₹122/29.0.

What were FISCHER latest quarterly results?

For Jun 2026, FISCHER MEDICAL VENTURE L (FISCHER) reported sales ₹0.72 Cr and net profit ₹-3.50 Cr (figures in ₹ crore unless noted).

What are FISCHER annual sales and net profit?

For TTM, FISCHER MEDICAL VENTURE L (FISCHER) shows sales of ₹14 Cr and net profit of ₹-13 Cr on the Fincrux profit & loss statement.

Who owns FISCHER MEDICAL VENTURE L (FISCHER)?

Latest shareholding for FISCHER MEDICAL VENTURE L (FISCHER) on Fincrux: Promoters 63.09% (Aug 2026), FIIs 5.57% (Aug 2026), DIIs 1.26% (Aug 2026), Public 30.09% (Aug 2026), No. of Shareholders 23,951% (Aug 2026).

Where can I find FISCHER MEDICAL VENTURE L (FISCHER) financials?

FISCHER MEDICAL VENTURE L (FISCHER) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show FISCHER balance sheet and cash flow?

Yes. The FISCHER MEDICAL VENTURE L (FISCHER) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 9:53